{
    "clinical_study": {
        "@rank": "154612", 
        "acronym": "iSWAT", 
        "arm_group": [
            {
                "arm_group_label": "real tDCS", 
                "arm_group_type": "Active Comparator", 
                "description": "patients will receive non-invasive and painless brain stimulation over the rain areas involved in swallowing.\ntDCS will be applied during swallowing therapy, during 20 minutes"
            }, 
            {
                "arm_group_label": "sham tDCS", 
                "arm_group_type": "Placebo Comparator", 
                "description": "this will be exactly as for \"real tDCS\" unless that the tDCS will be rapidly turned off, unbeknown from patients-therapist-examinator (double-blind trial)"
            }
        ], 
        "brief_summary": {
            "textblock": "In the acute phase of stroke, dysphagia (difficulty/inability to swallow) is a common\n      problem that can have serious consequences such as aspiration pneumonia, increased lenght of\n      hospitalisation, and death. It would be interesting to enhance the therapeutic effect of\n      swallowing retraining by means on non-invasive brain stimulation such as transcranial direct\n      current stimulation (tDCS).\n\n      Hypothesis: during the acute phase of stroke, applying tDCS over the brain during the\n      revalidation and/or supervised feeding improves dysphagia significantly when compared to\n      sham tDCS."
        }, 
        "brief_title": "Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Stroke", 
            "Dysphagia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Deglutition Disorders", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "tDCS will be used in a double-blind, randomized control trial in acute stroke patients\n      suffering from dysphagia.\n\n      After informed consent and recruitment, patients will be randomly (computer method)\n      allocated to real or sham tDCS, that will be applied during swallowing exercices/therapy or\n      supervised feeding.\n\n      Baseline and follow-up outcomes about dysphagia will be collected."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - acute stroke (ischemic / hemorrhagic) with dysphagia\n\n        Exclusion Criteria:\n\n          -  major swallowing impairment before the stroke\n\n          -  troubles of comprehension impairing communication\n\n          -  major cognitive dysfunction, neuro-degenerative disease, or major psychiatric\n             condition (e.g. depression, Alzheimer's disease, \u2026)\n\n          -  very unstable health issue (e.g. severe cardiac dyscfct, end-stage renal failure,\n             unstable diabetes, \u2026)\n\n          -  intracranial metal and/or devices excluding tDCS application\n\n          -  chronic intake of major drugs modifying brain activity (e.g. AEDs, antipsychotics)\n\n          -  regular use of alcohol or recreative drugs\n\n          -  epilepsy\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758991", 
            "org_study_id": "B039201111926"
        }, 
        "intervention": {
            "arm_group_label": [
                "real tDCS", 
                "sham tDCS"
            ], 
            "description": "tDCS is a safe and painless transcranial stimulation that modulates brain activity and could improve stroke recovery. Electrodes in soaked sponges are placed over specific brain regions and held with an elastic band. Direct current is then applied through the electrodes. The patients may feel nothing or a slight tingling under the electrodes.", 
            "intervention_name": "transcranial direct current stimulation (tDCS)", 
            "intervention_type": "Device", 
            "other_name": "Eldith PLUS tDCS, NeuroConn, Ilmenau, Germany"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 27, 2012", 
        "link": [
            {
                "description": "CHU Mont-Godinne UCL", 
                "url": "http://www.uclmontgodinne.be/prohome.php"
            }, 
            {
                "description": "Institute of NeuroScience (IoNS), Universit\u00e9 catholique de Louvain (UCL)", 
                "url": "http://www.uclouvain.be/ions.html"
            }
        ], 
        "location": {
            "contact": {
                "email": "katalin.defays@uclouvain.be", 
                "last_name": "Katalin de Fays, MSc", 
                "phone": "+3281423348"
            }, 
            "facility": {
                "address": {
                    "city": "Yvoir", 
                    "country": "Belgium", 
                    "state": "Namur", 
                    "zip": "5530"
                }, 
                "name": "University Hospital of Mont-Godinne : CHU Mont-Godinne UCL"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Therapeutic Impact of tDCS on Dysphagia in the Acute Phase of Stroke / Impact th\u00e9rapeutique de la tDCS Sur la Dysphagie en Phase Aigue de l'Accident Vasculaire c\u00e9r\u00e9bral", 
        "overall_contact": {
            "email": "katalin.defays@uclouvain.be", 
            "last_name": "Katalin de Fays, BSc", 
            "phone": "+32 81 42 33 48"
        }, 
        "overall_official": {
            "affiliation": "University Hospital of Mont-Godinne", 
            "last_name": "Yves Vandermeeren, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Belgium: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The patients will be asked to swallow radiocontrast agent liquid during RX (radiography) video-recording. The speed of swallowing, whether there is aspiration or stasis will be quantified off-line on videotape", 
                "measure": "VideoFluoroscopy (VFSS)", 
                "safety_issue": "No", 
                "time_frame": "baseline, end of acute stroke phase, follow up (3, 6, 12 months)"
            }, 
            {
                "description": "A laryngoscope (attached to a camera and a color monitor) will be passed through the nostril.\nThe patients will be asked to swallow small quantities of liquids and foods, and the quality of swallowing will be assessed off-line (videotaped examination).\nThe base of the tongue, pharynx and larynx will be viewed.", 
                "measure": "Fiberoptic Endoscopic Evaluation of Swallowing (FEES)", 
                "safety_issue": "No", 
                "time_frame": "baseline, end of acute stroke phase, follow up (3, 6, 12 months)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758991"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital of Mont-Godinne", 
            "investigator_full_name": "Yves Vandermeeren", 
            "investigator_title": "Professor (MD, PhD)", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The NIS Stroke Scale is a clinical scale developped to score the severity of acute stroke. Patients will be asked to make some movements, vision will be tested, whether there are difficult to speak and so on.", 
                "measure": "NIH Stroke Scale", 
                "safety_issue": "No", 
                "time_frame": "baseline, end of acute stroke phase, follow up (3, 6, 12 months)"
            }, 
            {
                "description": "the records of the acute stroke patients will be used to search for relevant clinical events.", 
                "measure": "clinical record", 
                "safety_issue": "No", 
                "time_frame": "baseline, end of acute stroke phase, follow up (3, 6, 12 months)"
            }, 
            {
                "description": "A quality-of-life (QOL) questionnaire specifically designed for patients with oropharyngeal dysphagia (SWAL-QOL) will be used, questions will be asked to the patients / proxies? The French version of the SWAL-QOL will be used", 
                "measure": "quality-of-life (QOL) questionnaire designed for dysphagia (SWAL-QOL)", 
                "safety_issue": "No", 
                "time_frame": "baseline, end of acute stroke phase, follow up (3, 6, 12 months)"
            }
        ], 
        "source": "University Hospital of Mont-Godinne", 
        "sponsors": {
            "collaborator": {
                "agency": "Universit\u00e9 catholique de Louvain (UCL), Institute of NeuroScience (IoNS)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital of Mont-Godinne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}